<?xml version="1.0" encoding="UTF-8"?>
<p id="Par53">Tocilizumab an anti-IL-6R antibody is known for its potential efficacy in reducing inflammatory response including the cytokine storm contributing to ARDS and even death [
 <xref ref-type="bibr" rid="CR4">4</xref>]. It is known to increase cholesterol levels, but there are conflicting reports on its effect on long term cardiac morbidity and mortality [
 <xref ref-type="bibr" rid="CR53">53</xref>].
</p>
